Login

Introducing YESCan: Streamlining Fenestration Product Data Submission to NRCan | Valmor Ruscheck - CEO of Natural Resources Canada 00:10:00

Share On Facebook Share On Twitter

Valmor Ruscheck is the CEO of Natural Resources Canada

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Streamlining Your Search for the Right Financial Advisor with Wealth Ramp
00:10:00
From Chaos to Hope: Johnson's Journey from Hardship to Education
00:10:00
Impact of Pandemic on Dividends, Outflows, and Work-from-Home Trends
00:10:00
Talon Metals Reports High-Grade Nickel and Copper Intercept in Raptor Zone
00:10:00
WilmerHale at Entrepreneurship@Cornell: Annual 2-Day Conference Highlights
00:10:00
Bass Metals: Revitalizing Graphite Production in Madagascar
00:10:00
Chairman and CEO of Iwatani Corporation, Mr. Akiji Makino, attends the 4th Hydrogen Energy Ministerial Meeting.
00:10:00
Tura Group CEO Stefan Eriksson Discusses Key Highlights in Q4 and 2023 Year-End Report | Stefan Eriksson ,CEO , TURA GROUP AB.
00:10:00
"Exploring ESG and Responsible Investing: A Discussion with State Street Global Advisors' Brie Williams, Hosted by SoFi's Brian Walsh"
00:10:00
Canada Zinc Metals: Advancing High-Grade Zinc Projects in British Columbia
00:10:00
Teoh Kok Lin, chief investment officer at Singular Asset Management Bhd., discusses investment strategies and market trends with Bloomberg's Susan Li.
00:10:00
Insights into French Biotech: Challenges and Opportunities in Healthcare Innovation Explored by Industry Expert | André Choulika, CEO,Cellectis SA.

© 2017 - Neuhu+